R. Repeat Dyslipidemia Evaluation in 1 to 2 Years (Patients NOT on Therapy)

objective

Provide appropriate clinical follow-up for patients not on therapy.

background

Because lipids tend to increase with advancing age, patients at initially low-risk for CVD events may over time, become patients at above-average risk or may develop concurrent health conditions (nephrotic syndrome, hypothyroidism, and DM) that can declare as dyslipidemia.  Periodic reassessment of serum cholesterol and TGs permits timely identification and treatment of such individuals.

recommendations

1. If the initial dyslipidemia screening reveals TC >200 mg/dL, or fasting LDL-C >130 mg/dL or HDL-C <40 mg/dL, but LDL-C level is under the recommended goal level based upon CV risk, the patient will be at low-risk for lipid-related events over a one to two-year period and thus, should be reevaluated for dyslipidemia in one to two years.